Compare TTRX & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TTRX | FCCO |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 298.8M | 320.5M |
| IPO Year | 2025 | 2012 |
| Metric | TTRX | FCCO |
|---|---|---|
| Price | $16.25 | $33.81 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 91.4K | 39.2K |
| Earning Date | 05-31-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.16% |
| EPS Growth | N/A | ★ 36.46 |
| EPS | N/A | ★ 1.39 |
| Revenue | N/A | ★ $922,000.00 |
| Revenue This Year | N/A | $30.67 |
| Revenue Next Year | N/A | $5.87 |
| P/E Ratio | ★ N/A | $24.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.57 | $25.92 |
| 52 Week High | $14.50 | $35.74 |
| Indicator | TTRX | FCCO |
|---|---|---|
| Relative Strength Index (RSI) | 75.45 | 46.32 |
| Support Level | $3.49 | $32.44 |
| Resistance Level | N/A | $33.70 |
| Average True Range (ATR) | 1.31 | 0.79 |
| MACD | 0.32 | -0.05 |
| Stochastic Oscillator | 88.29 | 39.32 |
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.